Clinical Trial Update: Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion of a study evaluating two digital therapeutics for preventing episodic migraine in patients on CGRP therapy (ReMMiD-C).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Drugs mentioned

• Digital Therapeutic A
• Digital Therapeutic B

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Migraine, Episodic Migraine | Phase 3 | Status: COMPLETED